Download PDF
Klinische Neurophysiologie 2015; 46(03): 146-152
DOI: 10.1055/s-0035-1559717
Originalia
© Georg Thieme Verlag KG Stuttgart · New York

Biomechanische Ganganalyse von neurodegenerativen Parkinson-Syndromen

Biomechanical Gait Analysis in Neurodegenerative Parkinsonian Syndromes
T. Wolfsegger
1   Abteilung für Neurologie, Landesnervenklinik Wagner-Jauregg, Universitätslehrkrankenhaus, Linz, Österreich
,
R. Topakian
1   Abteilung für Neurologie, Landesnervenklinik Wagner-Jauregg, Universitätslehrkrankenhaus, Linz, Österreich
2   Abteilung für Neurologie, Klinikum Wels-Grieskirchen, Wels, Österreich
,
H. Schwameder
3   Institut für Sport- und Bewegungswissenschaften, Universität Salzburg, Salzburg, Österreich
› Author Affiliations
Further Information

Publication History

Publication Date:
25 September 2015 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Einführung: Der Einsatzbereich biomechanischer Messverfahren bei der Evaluierung von Gangstörungen in der Neurologie wird zusehends häufiger. Die Studienlage zu vergleichenden biomechanischen Ganganalysen hypokinetisch-rigider Gangstörungen im Rahmen eines Parkinson-Syndroms ist derzeit noch gering. Das Ziel dieser Studie ist, Unterschiede der Gangfunktion bei Patienten mit idiopathischen Parkinson-Syndrom (IPS) und Patienten mit einem atypischen Parkinson-Syndrom (APS) zu objektivieren.

Methode: Mithilfe kinematischer und kinetischer Bewegungsanalyseverfahren wurde die Gangmotorik von IPS Patienten (n=12); APS Patienten (n=12) und einer gesunden Kontrollgruppe (K, n=12) analysiert.

Ergebnisse: APS Patienten gingen signifikant langsamer, kleinschrittiger und mit verlängerten Bodenkontaktphasen als IPS Patienten und einer gesunden K Gruppe. Zwischen den neurodegenerativen Erkrankungsgruppen APS und IPS wurde in den Bewegungsamplituden der oberen Extremitäten keine signifikante Differenz quantifiziert. An den unteren Extremitäten überwiegt eine proximale Bewegungseinschränkung der APS gegenüber IPS. Eine geringere Auftrittskraft und Abstoßkraft während der Bodenkontaktphase ist bei den APS im Vergleich zu IPS und K objektivierbar.

Schlussfolgerung: Mithilfe biomechanischer Ganganalyseverfahren können innerhalb der hypokinetisch-rigiden Gangstörungen unterschiedliche Gangcharakteristika objektiviert werden. Der Einsatzbereich könnte im klinischen Alltag für differenzialdiagnostische und therapeutische Überlegungen hilfreich sein.

Abstract

Background: Biomechanical measurement of neurological gait disorders has been increasingly used in recent years. However, prospective comparative studies of hypokinetic gait disorders are still sparse. The aim of this study was an objective comparison of gait parameters in subjects with idiopathic Parkinson’s disease (IPD, n=12), atypical parkinsonian syndromes (APS, n=12), and controls (n=12).

Methods: We quantified kinetics and kinematics in upper and lower extremities, trunk, and head in sagittal as well as spatiotemporal gait parameters.

Results: We found a significantly reduced walking speed with shortened step length and prolonged ground contact phase in APS subjects compared to PD subjects and controls. In addition, APS patients had more hypokinetic rigidity in lower extremities than in upper extremities compared to IPD and controls. Furthermore, loading force under the heel and active force for gait propulsion in the forefoot were reduced in APS compared to IPD and controls.

Conclusion: Our results suggest that biomechanical gait analysis may help clinicians to objectively differentiate typical gait characteristics in clinically similar hypokinetic gait disorders.

Schlüsselwörter

Parkinson-Syndrom - Atypisches Parkinson-Syndrom - Gangstörungen - Ganganalyse

Key words

parkinson’s disease - atypical parkinsonian syndromes - gait disorders - gait analysis
 

  • Literatur

  • 1 Ellis T, De Goede CJ, Feldman RG et al. Efficacy of a physical therapy program in patients with Parkinson’s disease: a randomized controlled trial. Arch Phys Med Rehabil 2005; 86: 626-632
    CrossrefPubMedGoogle Scholar
  • 2 Knutsson E. An analysis of parkinsonian gait. Brain 1972; 95: 475-486
    CrossrefPubMedGoogle Scholar
  • 3 Svehlík M, Zwick EB, Steinwender G et al. Gait analysis in patients with Parkinson’s disease off dopaminergic therapy. Arch Phys Med Rehabil 2009; 90: 1880-1886
    CrossrefPubMedGoogle Scholar
  • 4 Snijders AH, van de Warrenburg BP, Giladi N et al. Neurological gait disorders in elderly people: clinical approach and classification. Lancet Neurol 2007; 6: 63-74
    CrossrefPubMedGoogle Scholar
  • 5 Rizzone M, Pedotti A, Bergamasco B et al. High-frequency electrical stimulation of the subthalamic nucleus in Parkinson’s disease: kinetic and kinematic gait analysis. Neurol Sci 2002; 23: 103-104
    CrossrefPubMedGoogle Scholar
  • 6 Ferrarin M, Rizzone M, Lopiano L et al. Effects of subthalamic nucleus stimulation and L-dopa in trunk kinematics of patients with Parkinson’s disease. Gait Posture 2004; 19: 164-171
    CrossrefPubMedGoogle Scholar
  • 7 Morris M, Iansek R, McGinley J et al. Three dimensional gait biomechanics in Parkinson’s disease: evidence for a centrally mediated amplitude regulation disorder. Mov Disord 2005; 20: 40-50
    CrossrefPubMedGoogle Scholar
  • 8 Cole MH, Silburn PA, Wood JM et al. Falls in Parkinson’s disease: kinematic evidence for impaired head and trunk control. Mov Disord 2010; 30: 2369-2378
    PubMedGoogle Scholar
  • 9 Strzelczyk A, Möller JC, Stamelou M et al. Atypische Parkinson-Syndrome. Der Nervenarzt 2008; 79: 1203-1222
    CrossrefPubMedGoogle Scholar
  • 10 Wenning GK, Litvan I, Tolosa E. Milestones in Atypical and Secondary Parkinsonisms. Mov Disord 2011; 26: 1083-1095
    CrossrefPubMedGoogle Scholar
  • 11 Bloem RB, Bhatia KP. Gait and balance in basal ganglia disorders. In: Bronstein AM, Brandt T, Woollacott MH, Nutt JG. (eds.) Clinical Disorders of Balance, Posture and Gait. (2nd edt.) Arnold; London: 2004: 173-207
    Google Scholar
  • 12 Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999; 56: 33-39
    CrossrefPubMedGoogle Scholar
  • 13 Litvan I. Progressive supranuclear palsy revisited. Acta Neurol Scand 1998; 98: 73-84
    CrossrefPubMedGoogle Scholar
  • 14 Gilman S, Wenning GK, Low PA et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008; 71: 670-676
    CrossrefPubMedGoogle Scholar
  • 15 Hausdorff JM. Gait dynamics in Parkinson’s disease: Common and distinct behaviour among stride length, gait variability, and fractal-like scaling. CHAOS 2009; 19: 1054-1500
    PubMedGoogle Scholar
  • 16 Stolze H, Kuhtz-Buschbeck JP, Drücke H. Comparative analysis of the gait disorder of normal pressure hydrocephalus and Parkinson’s disease. J Neurol Neurosurg Psychiatry 2001; 70: 289-297
    CrossrefPubMedGoogle Scholar
  • 17 Morris M, Iansek R, Matyas T et al. Abnormalities in stride length-cadence relation in Parkinsonian gait. Mov Disord 1998; 13: 61-69
    CrossrefPubMedGoogle Scholar
  • 18 Bensimon G, Ludolph A, Agid Y et al. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS study. Brain 2009; 132 (Part 1) 156-171
    PubMedGoogle Scholar
  • 19 Stolze H, Vieregge P, Deuschl G. Gangstörungen in der Neurologie. Nervenarzt 2008; 79: 485-499
    CrossrefPubMedGoogle Scholar
  • 20 Ashour R, Jankovic J. Joint and Skeletal Deformities in Parkinson’s Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy. Mov Disord 2006; 21: 1856-1863
    CrossrefPubMedGoogle Scholar
  • 21 Köllensperger M, Geser F, Seppi K et al. Red Flags for Multiple System Atrophy. Mov Disord 2008; 23: 1093-1099
    CrossrefPubMedGoogle Scholar
  • 22 Azher SN, Jankovic J. Camptocormia: pathogenesis, classification, and response to therapy. Neurology 2005; 65: 355-359
    CrossrefPubMedGoogle Scholar
  • 23 van de Warrenburg BP, Cordivari C, Ryan AM et al. The phenomenon of disproportionate antecollis in Parkinson’s disease and multiple system atrophy. Mov Disord 2007; 22: 2325-2331
    CrossrefPubMedGoogle Scholar
  • 24 Kimmeskamp S, Hennig EM. Heel to toe motion characteristics in Parkinson patients during free walking. Clin Biomech 2001; 16: 806-812
    CrossrefPubMedGoogle Scholar
  • 25 Caliandro P, Ferrarin M, Cioni M et al. Levodopa effect on electromyographic activation patterns of tibialis anterior muscle during walking in Parkinson’s disease. Gait Posture 2001; 33: 436-441
    PubMedGoogle Scholar
  • 26 Abbruzzese G, Berardelli A. Sensorimotor Integration in Movement Disorders. Mov Disord 2003; 18: 231-240
    CrossrefPubMedGoogle Scholar
  • 27 Maschke M, Tuite PJ, Krawczewski K et al. Perception of Heaviness in Parkinson’s Disease. Mov Disord 2006; 21: 1013-1018
    CrossrefPubMedGoogle Scholar
  • 28 Takakusaki K, Tomita N, Yano M. Substrates for normal gait and pathophysiology of gait disturbances with respect to the basalganglia dysfunction. J Neurol 2008; 255 (Supp 4) 19-29
    PubMedGoogle Scholar
  • 29 Riskowski JL, Mikesky AE, Bahamonde RE et al. Proprioception, gait kinematics and rate of loading during walking: Are they related?. J Musculoskelet Neuronal Interact 2005; 5: 379-387
    PubMedGoogle Scholar
  • 30 Schrader C, Peschel T, Däuper J et al. Changes in processing of propriozeptive information in Parkinson’s disease and multiple system atrophy. Clin Neurophysiol 2005; 119: 1139-1146
    PubMedGoogle Scholar